Segment Disclosures - Summary Information for the Reportable Segments (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended
	Mar. 31, 2023	Jan. 31, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			$ 525,678			$ 498,372
Government grant income			137			6,552
Less: Interest income			(6,163)			(5,494)
Healthpeak’s share of unconsolidated joint venture total revenues			23,256			20,208
Healthpeak’s share of unconsolidated joint venture government grant income			228			648
Noncontrolling interests’ share of consolidated joint venture total revenues			(9,106)			(8,877)
Operating expenses			(223,088)			(207,247)
Healthpeak’s share of unconsolidated joint venture operating expenses			(16,493)			(14,837)
Noncontrolling interests’ share of consolidated joint venture operating expenses			2,635			2,621
Adjustments to NOI			(4,624)			(17,666)
Adjusted NOI			292,460			274,280
Plus: Adjustments to NOI			4,624			17,666
Interest income			6,163			5,494
Interest expense			(47,963)			(37,586)
Depreciation and amortization			(179,225)			(177,733)
General and administrative			(24,547)			(23,831)
Transaction costs			(2,425)			(296)
Impairments and loan loss reserves, net			2,213			(132)
Gain (loss) on sales of real estate, net			81,578			3,856
Other income (expense), net			772			18,316
Less: Government grant income			(137)			(6,552)
Less: Healthpeak’s share of unconsolidated joint venture NOI			(6,991)			(6,019)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			6,471			6,256
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			132,993			73,719
Income tax benefit (expense)			(302)			(777)
Equity income (loss) from unconsolidated joint ventures			1,816			2,084
Income (loss) from continuing operations			134,507			75,026
Income (loss) from discontinued operations			0			317
Net income (loss)			134,507			75,343
Corporate Non-segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			0			0
Government grant income			0			0
Less: Interest income			0			0
Healthpeak’s share of unconsolidated joint venture total revenues			0			0
Healthpeak’s share of unconsolidated joint venture government grant income			0			0
Noncontrolling interests’ share of consolidated joint venture total revenues			0			0
Operating expenses			0			0
Healthpeak’s share of unconsolidated joint venture operating expenses			0			0
Noncontrolling interests’ share of consolidated joint venture operating expenses			0			0
Adjustments to NOI			0			0
Adjusted NOI			0			0
Plus: Adjustments to NOI			0			0
Interest income			0			0
Interest expense			(44,227)			(34,685)
Depreciation and amortization			0			0
General and administrative			(24,547)			(23,831)
Transaction costs			(1,916)			0
Impairments and loan loss reserves, net			0			0
Gain (loss) on sales of real estate, net			0			0
Other income (expense), net			1,231			909
Less: Government grant income			0			0
Less: Healthpeak’s share of unconsolidated joint venture NOI			0			0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			0			0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			(69,459)			(57,607)
Income tax benefit (expense)			(302)			(777)
Equity income (loss) from unconsolidated joint ventures			0			0
Income (loss) from continuing operations			(69,761)			(58,384)
Income (loss) from discontinued operations			0			317
Net income (loss)			(69,761)			(58,067)
Life Science
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net		$ 60,000				4,000
Life Science | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			205,464			194,055
Government grant income			0			0
Less: Interest income			0			0
Healthpeak’s share of unconsolidated joint venture total revenues			2,165			1,431
Healthpeak’s share of unconsolidated joint venture government grant income			0			0
Noncontrolling interests’ share of consolidated joint venture total revenues			(143)			(57)
Operating expenses			(57,566)			(48,189)
Healthpeak’s share of unconsolidated joint venture operating expenses			(1,182)			(483)
Noncontrolling interests’ share of consolidated joint venture operating expenses			40			19
Adjustments to NOI			(832)			(14,112)
Adjusted NOI			147,946			132,664
Plus: Adjustments to NOI			832			14,112
Interest income			0			0
Interest expense			0			0
Depreciation and amortization			(75,582)			(78,138)
General and administrative			0			0
Transaction costs			(158)			(292)
Impairments and loan loss reserves, net			0			0
Gain (loss) on sales of real estate, net			60,498			3,856
Other income (expense), net			4			(9)
Less: Government grant income			0			0
Less: Healthpeak’s share of unconsolidated joint venture NOI			(983)			(948)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			103			38
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			132,660			71,283
Income tax benefit (expense)			0			0
Equity income (loss) from unconsolidated joint ventures			598			966
Income (loss) from continuing operations			133,258			72,249
Income (loss) from discontinued operations			0			0
Net income (loss)			133,258			72,249
Medical Office
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net	$ 21,000			$ 1,000	$ 10,000
Medical Office | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			186,967			177,263
Government grant income			0			0
Less: Interest income			0			0
Healthpeak’s share of unconsolidated joint venture total revenues			745			732
Healthpeak’s share of unconsolidated joint venture government grant income			0			0
Noncontrolling interests’ share of consolidated joint venture total revenues			(8,963)			(8,820)
Operating expenses			(64,398)			(61,170)
Healthpeak’s share of unconsolidated joint venture operating expenses			(305)			(299)
Noncontrolling interests’ share of consolidated joint venture operating expenses			2,595			2,602
Adjustments to NOI			(3,821)			(3,546)
Adjusted NOI			112,820			106,762
Plus: Adjustments to NOI			3,821			3,546
Interest income			0			0
Interest expense			(1,920)			(1,036)
Depreciation and amortization			(71,158)			(67,773)
General and administrative			0			0
Transaction costs			(132)			(4)
Impairments and loan loss reserves, net			0			0
Gain (loss) on sales of real estate, net			21,312			0
Other income (expense), net			204			10,937
Less: Government grant income			0			0
Less: Healthpeak’s share of unconsolidated joint venture NOI			(440)			(433)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			6,368			6,218
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			70,875			58,217
Income tax benefit (expense)			0			0
Equity income (loss) from unconsolidated joint ventures			189			200
Income (loss) from continuing operations			71,064			58,417
Income (loss) from discontinued operations			0			0
Net income (loss)			71,064			58,417
CCRC | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			127,084			121,560
Government grant income			137			6,552
Less: Interest income			0			0
Healthpeak’s share of unconsolidated joint venture total revenues			0			0
Healthpeak’s share of unconsolidated joint venture government grant income			0			333
Noncontrolling interests’ share of consolidated joint venture total revenues			0			0
Operating expenses			(101,124)			(97,888)
Healthpeak’s share of unconsolidated joint venture operating expenses			0			0
Noncontrolling interests’ share of consolidated joint venture operating expenses			0			0
Adjustments to NOI			50			0
Adjusted NOI			26,147			30,557
Plus: Adjustments to NOI			(50)			0
Interest income			0			0
Interest expense			(1,816)			(1,865)
Depreciation and amortization			(32,485)			(31,822)
General and administrative			0			0
Transaction costs			(219)			0
Impairments and loan loss reserves, net			0			0
Gain (loss) on sales of real estate, net			0			0
Other income (expense), net			(667)			6,511
Less: Government grant income			(137)			(6,552)
Less: Healthpeak’s share of unconsolidated joint venture NOI			0			(333)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			0			0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			(9,227)			(3,504)
Income tax benefit (expense)			0			0
Equity income (loss) from unconsolidated joint ventures			0			539
Income (loss) from continuing operations			(9,227)			(2,965)
Income (loss) from discontinued operations			0			0
Net income (loss)			(9,227)			(2,965)
Other Non-reportable | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			6,163			5,494
Government grant income			0			0
Less: Interest income			(6,163)			(5,494)
Healthpeak’s share of unconsolidated joint venture total revenues			20,346			18,045
Healthpeak’s share of unconsolidated joint venture government grant income			228			315
Noncontrolling interests’ share of consolidated joint venture total revenues			0			0
Operating expenses			0			0
Healthpeak’s share of unconsolidated joint venture operating expenses			(15,006)			(14,055)
Noncontrolling interests’ share of consolidated joint venture operating expenses			0			0
Adjustments to NOI			(21)			(8)
Adjusted NOI			5,547			4,297
Plus: Adjustments to NOI			21			8
Interest income			6,163			5,494
Interest expense			0			0
Depreciation and amortization			0			0
General and administrative			0			0
Transaction costs			0			0
Impairments and loan loss reserves, net			2,213			(132)
Gain (loss) on sales of real estate, net			(232)			0
Other income (expense), net			0			(32)
Less: Government grant income			0			0
Less: Healthpeak’s share of unconsolidated joint venture NOI			(5,568)			(4,305)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			0			0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			8,144			5,330
Income tax benefit (expense)			0			0
Equity income (loss) from unconsolidated joint ventures			1,029			379
Income (loss) from continuing operations			9,173			5,709
Income (loss) from discontinued operations			0			0
Net income (loss)			$ 9,173			$ 5,709